UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Diabetologia, 2012-06, Vol.55 (6), p.1577-1596

2012

Volltextzugriff (PDF)

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

Diabetologia, 2009, Vol.52 (1), p.17-30

2009

Volltextzugriff (PDF)

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293-1297

2013

Volltextzugriff (PDF)

Ecology of Wildfire Residuals in Boreal Forests

Ajith Perera, Lisa Buse

1, 2014

Volltextzugriff (PDF)

The metabolic syndrome : time for a critical appraisal joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

Diabetologia, 2005-09, Vol.48 (9), p.1684-1699

2005

Volltextzugriff (PDF)

Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay

Clinical biochemistry, 2017-06, Vol.50 (9), p.475-480

2017

Volltextzugriff (PDF)

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy : A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

Diabetologia, 2006-08, Vol.49 (8), p.1711-1721

2006

Volltextzugriff (PDF)

P1085 Impact et rôle du liraglutide, un analogue du GPL-1 humain, dans le diabète de type-2 : le rationnel et le design de l’étude LEADER® évaluant les paramètres cardiovasculaires

Diabetes & metabolism, 2013-03, Vol.39, p.A51-A51

2013

Volltextzugriff (PDF)

Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR

Osteoporosis international, 2020, Vol.31 (1), p.203-207

2020

Volltextzugriff (PDF)

Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study

Diabetes, obesity & metabolism, 2014-12, Vol.16 (12), p.1247-1256

2014

Volltextzugriff (PDF)

Endangered Longhorn Beetle Associated with Old Oaks and Its Possible Role as an Ecosystem Engineer

Conservation biology, 2008-04, Vol.22 (2), p.329-337

2008

Volltextzugriff (PDF)

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial

Diabetes, obesity & metabolism, 2015-10, Vol.17 (10), p.965-973

2015

Volltextzugriff (PDF)

Toward rigorous use of expert knowledge in ecological research

Ecosphere (Washington, D.C), 2013-07, Vol.4 (7), p.art83-26

2013

Volltextzugriff (PDF)

No holds barred sport fighting: a 10 year review of mixed martial arts competition

British journal of sports medicine, 2006-02, Vol.40 (2), p.169-172

Buse, G J

2006

Volltextzugriff (PDF)

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Diabetic medicine, 2013-11, Vol.30 (11), p.1293

2013

Volltextzugriff (PDF)

A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States

Journal of clinical epidemiology, 2003-02, Vol.56 (2), p.164-170

2003

Volltextzugriff (PDF)

Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11–14 year olds: The HEALTHY Study

International Journal of Obesity, 2016-07, Vol.40 (7), p.1157-1163

2016

Volltextzugriff (PDF)

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Diabetes, obesity & metabolism, 2013-01, Vol.15 (1), p.42-54

2013

Volltextzugriff (PDF)

Is insulin the most effective injectable antihyperglycaemic therapy?

Diabetes, obesity & metabolism, 2015-02, Vol.17 (2), p.145-151

2015

Volltextzugriff (PDF)

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

Diabetes, obesity & metabolism, 2016-01, Vol.18 (1), p.40-48

2016

Volltextzugriff (PDF)

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: Update regarding the thiazolidinediones

Diabetologia, 2008-01, Vol.51 (1), p.8-11

2008

Volltextzugriff (PDF)

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Diabetes care, 2018-08, Vol.41 (8), p.1792-1800

2018

Volltextzugriff (PDF)

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

Diabetologia, 2012-06, Vol.55 (6), p.1641-1650

2012

Volltextzugriff (PDF)

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

BMJ, 2010-01, Vol.340 (jan08 1), p.b4909-b4909

2010

Volltextzugriff (PDF)

Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study

Diabetic medicine, 2011-06, Vol.28 (6), p.715-723

2011

Volltextzugriff (PDF)

1 – 25 von 1.288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.030)
Mit Volltextzugriff
(1.040)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(667)
Life Sciences & Biomedicine
(572)
Humans
(423)
Male
(263)
Female
(248)
Diabetes
(164)
Middle Aged
(164)
Endocrinology & Metabolism
(159)
Biological And Medical Sciences
(148)
Aged
(119)
Animals
(118)
Adult
(108)
Medical Sciences
(104)
Diabetes Mellitus, Type 2 - Drug Therapy
(101)
Risk Factors
(95)
Diabetes Mellitus
(87)
Neurosciences & Neurology
(85)
Hypoglycemic Agents - Therapeutic Use
(76)
Clinical Neurology
(75)
General & Internal Medicine
(71)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial

Ecology of Wildfire Residuals in Boreal Forests

The metabolic syndrome : time for a critical appraisal joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

Clinical implications for biochemical diagnostic thresholds of adrenal sufficiency using a highly specific cortisol immunoassay

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy : A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

P1085 Impact et rôle du liraglutide, un analogue du GPL-1 humain, dans le diabète de type-2 : le rationnel et le design de l’étude LEADER® évaluant les paramètres cardiovasculaires

Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR

Dipeptidyl-peptidase-4 inhibitors and pancreatic cancer: a cohort study

Endangered Longhorn Beetle Associated with Old Oaks and Its Possible Role as an Ecosystem Engineer

One-year efficacy and safety of a fixed combination of insulin degludec and liraglutide in patients with type 2 diabetes: results of a 26-week extension to a 26-week main trial

Toward rigorous use of expert knowledge in ecological research

No holds barred sport fighting: a 10 year review of mixed martial arts competition

Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN(®) Basal-Bolus Type 1): 2-year results of a randomized clinical trial

A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States

Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11–14 year olds: The HEALTHY Study

Weight change with liraglutide and comparator therapies: an analysis of seven phase 3 trials from the liraglutide diabetes development programme

Is insulin the most effective injectable antihyperglycaemic therapy?

Benefits of combination of insulin degludec and liraglutide are independent of baseline glycated haemoglobin level and duration of type 2 diabetes

Management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: Update regarding the thiazolidinediones

Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study

Patient-reported outcomes are superior in patients with Type 2 diabetes treated with liraglutide as compared with exenatide, when added to metformin, sulphonylurea or both: results from a randomized, open-label study

Suchergebnisse filtern